Endo International plc, a specialty pharmaceutical company, manufactures and sells generic and branded pharmaceuticals in the United States and internationally. Its Branded Pharmaceuticals segment provides branded prescription products, including XIAFLEX to treat adult patients with Dupuytren's contracture; SUPPRELIN LA to treat central precocious puberty in children; NASCOBAL nasal spray to treat vitamin B12 deficiency; AVEED to treat hypogonadism; QWO, an injectable treatment for moderate to severe cellulite in the buttocks of adult women; PERCOCET to treat moderate-to-moderately-severe pain; TESTOPEL an implantable pellet indicated for TRT in conditions associated with a deficiency or absence of endogenous testosterone; EDEX to treat erectile dysfunction; LIDODERM a topical patch product containing lidocaine for the relief of pain; and products for the pain management and urology. The company's Sterile Injectables segment manufactures VASOSTRICT, a vasopressin injection; ADRENALIN, a non-selective adrenergic agonist; and APLISOL, which is a sterile aqueous solution, as well as generic sterile injectable products, including ertapenem for injections and ephedrine sulfate injections. Its Generic Pharmaceuticals segment offers solid oral extended-release, solid oral immediate-release, liquids, semi-solids, patches, powders, ophthalmic products, and sprays. The company's International Pharmaceuticals segment offers specialty pharmaceutical products in various therapeutic areas comprising attention deficit hyperactivity disorder, pain, women's health, oncology, and transplantation. The company sells its branded pharmaceuticals and generics to specialty physicians, retailers, clinics, government agencies, doctors, retail and specialty pharmacies, and specialty distributors. Endo International plc was founded in 1920 and is headquartered in Dublin, Ireland. On August 16, 2022, Endo International plc, along with its affiliates, filed a voluntary petition for reorganization under Chapter 11 in the U.S. Bankruptcy Court for the Southern District of New York.
Show more...
VD
Blaise Coleman
Anställda
2931
Land
IE
ISIN
IE00BJ3V9050
WKN
000A1XE6M
Noteringar
0 Comments
Dela dina tankar
FAQ
Vad är Endo Internationals aktiekurs idag?▼
Det aktuella priset för ENDPQ är $0 USD — det har ökat med +0% under de senaste 24 timmarna. Följ Endo International-aktiens utveckling närmare i diagrammet.
Vad är Endo Internationals aktiesymbol?▼
Beroende på börsen kan aktiesymbolen variera. Till exempel handlas Endo International-aktien på börsen under symbolen ENDPQ.
Vad var Endo Internationals intäkter förra året?▼
Endo Internationals intäkter för det senaste året uppgår till 2.01B USD.
Vad var Endo Internationals nettoresultat förra året?▼
ENDPQs nettovinst för det senaste året är -2.45B USD.
Hur många anställda har Endo International?▼
Från och med april 01, 2026 har företaget 2,931 anställda.
I vilken sektor finns Endo International?▼
Endo International verkar inom sektorn Professional, Scientific, and Technical Services.
När genomförde Endo International en aktiesplit?▼
Endo International har inte haft några splitar nyligen.
Var ligger Endo Internationals huvudkontor?▼
Endo International har sitt huvudkontor i Dublin, IE.